NCT00446147View on ClinicalTrials.gov

Study of Pyridoxine for Hand-Foot Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

389

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Hand-foot Syndrome
Interventions
DRUG

Pyridoxine

100mg BID/daily, Per oral

DRUG

Placebo

placebo 100mg BID/daily, Per oral

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT00446147 - Study of Pyridoxine for Hand-Foot Syndrome | Biotech Hunter | Biotech Hunter